2010
DOI: 10.1186/1471-2407-10-229
View full text
|
|
Share

Abstract: BackgroundExposure of cancer cells to chemotherapeutic agents may result in reduced sensitivity to structurally unrelated agents, a phenomenon known as multidrug resistance, MDR. The purpose of this study is to investigate cell growth inhibition of wild type and the corresponding MDR cells by Tumor Treating Fields - TTFields, a new cancer treatment modality that is free of systemic toxicity. The TTFields were applied alone and in combination with paclitaxel and doxorubicin.MethodsThree pairs of wild type/MDR c…

Expand abstract

Search citation statements

Order By: Relevance

Paper Sections

0
0
0
0
0

Citation Types

0
38
0

Publication Types

Select...

Relationship

0
0

Authors

Journals